Interferon-α inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway

Journal of General Virology

Volumn 82, Issue 4, 2001, Pages 723-733

  Frese, M ^a   Pietschmann, T ^a   Moradpour, D ^a   Haller, O ^a   Bartenschlager, R ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; GUANOSINE TRIPHOSPHATASE; VIRUS PROTEIN; VIRUS RNA;

ANTIVIRAL ACTIVITY; ARTICLE; CELL STRAIN; CONTROLLED STUDY; GENE OVEREXPRESSION; GENETIC TRANSFECTION; HEPATITIS C VIRUS; HEPATOMA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; MUTANT; NORTHERN BLOTTING; PRIORITY JOURNAL; REPLICON; RNA REPLICATION; VIRUS GENOME; VIRUS INHIBITION; WESTERN BLOTTING;

HEPATITIS C VIRUS; RNA VIRUSES;

EID: 0035065277     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/0022-1317-82-4-723     Document Type: Article

References (53)

1. cDNA structures and regulation of two interferon-induced human Mx proteins
2. Isolation of Thogoto virus from Rhipicephalus bursa ticks in western Sicily
3. Correlation of interferon-induced expression of MxA mRNA in peripheral blood mononuclear cells with the response of patients with chronic active hepatitis C to IFN-α therapy
4. Mx transgenic mice - Animal models of health
5. Replication of hepatitis C virus
6. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction
7. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome
8. Factors predictive of a beneficial response to therapy of hepatitis C
9. Comparison of full-length sequences of interferon-sensitive and resistant hepatitis C virus 1b. Sensitivity to interferon is conferred by amino acid substitutions in the NS5A region
10. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C virus 1b infection
11. In vivo and in vitro induction of MxA protein in peripheral blood mononuclear cells from patients chronically infected with hepatitis C virus
12. Therapeutic options for HCV - Management of the infected individual
13. Human MxA protein inhibits tick-borne Thogoto virus but not Dhori virus
14. Inhibition of bunyaviruses, phleboviruses, and hantaviruses by human MxA protein
15. Mx proteins: Mediators of innate resistance to RNA viruses
16. Human MxA protein protects mice lacking a functional alpha/beta interferon system against La Crosse virus and other lethal viral infections
17. Identification of a single nucleotide polymorphism in the MxA gene promoter (G/T at nt - 88) correlated with the response of hepatitis C patients to interferon
18. Hepatitis C: The clinical spectrum of disease
19. Treatment of chronic non-A, non-B hepatitis with recombinant human alpha interferon. A preliminary report
20. Strong transient expression of the type I interferon-induced MxA protein in hepatitis A but not in acute hepatitis B and C
21. The effect of virus-immune hosts on Thogoto virus infection of the tick, Rhipicephalus appendiculatus
22. Inhibition of puumala and tula hantaviruses in Vero cells by MxA protein
23. Impaired antiviral response in human hepatoma cells
24. Evading the interferon response: Hepatitis C virus and the interferon-induced protein kinase, PKR
25. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
26. Human MxA protein confers resistance to Semliki Forest virus and inhibits the amplification of a Semliki Forest virus-based replicon in the absence of viral structural proteins
27. Interferon-inducible Mx proteins in fish
28. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line
29. Mutations in hepatitis C virus RNAs conferring cell culture adaptation
30. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C
31. Intrahepatic MxA and PKR protein expression in chronic hepatitis C virus infection
32. Inhibition of influenza C viruses by human MxA protein
33. Current and evolving therapies for hepatitis C
34. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium
35. Resistance to influenza virus and vesicular stomatitis virus conferred by expression of human MxA protein
36. Human and mouse Mx proteins inhibit different steps of the influenza virus multiplication cycle
37. Enhanced virus resistance of transgenic mice expressing the human MxA protein
38. Characterization of cell lines carrying self-replicating hepatitis C virus RNAs
39. Dominant-negative mutants of human MxA protein: Domains in the carboxy-terminal moiety are important for oligomerization and antiviral activity
40. Overview of hepatitis C virus genome structure, polyprotein processing, and protein properties
41. Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: Proposals for standardization
42. Cell type-specific MxA-mediated inhibition of measles virus transcription in human brain cells
43. MxA-dependent inhibition of measles virus glycoprotein synthesis in a stably transfected human monocytic cell line
44. Interferon-induced human protein with homology to protein Mx of influenza virus-resistant mice
45. How cells respond to interferons
46. Hepatitis C virus: Evasion of the interferon-induced antiviral response
47. Natural history and disease manifestations of hepatitis C infection
48. Genotype and viral load as prognostic indicators in the treatment of hepatitis C
49. Subcellular localization, stability, and trans-cleavage competence of the hepatitis C virus NS3-NS4A complex expressed in tetracycline-regulated cell lines
50. Hepatitis C: Global prevalence
51. Inhibition of human parainfluenza virus-3 replication by interferon and human MxA
52. Interferon action in triply deficient mice reveals the existence of alternative antiviral pathways